CIRM Funded Clinical Trials
A PHASE 1B STUDY EVALUATING THE SAFETY AND EFFICACY OF AN ALLOGENEIC CELL THERAPY IN SUBJECTS WITH CLEAR CELL RENAL CELL CARCINOMA (ccRCC)
Disease Area:
Trial Sponsor:
Allogene Therapeutics
Trial Stage:
Phase 1
Trial Status:
Launching
Targeted Enrollment:
N/A
